American College of Cardiology

VIDEO: Novel drug misses mark for MI prevention, but shows promise

Posted on: 31/03/2014 - 19:05

WASHINGTON – In the large STABILITY trial, darapladib did not significantly reduce the primary endpoint of cardiovascular death, MI, or stroke in patients with stable coronary disease. The novel...

Field of Interest: Cardiology

Type: News Item

Colchicine called first-line pericarditis treatment

Posted on: 31/03/2014 - 17:35

WASHINGTON – Adding colchicine to standard anti-inflammatory treatment for patients with recurrent pericarditis led to significantly fewer subsequent recurrences than did standard treatment alone in...

Field of Interest: Cardiology

Type: News Item

No improvements in left ventricular function with metformin after myocardial infarction

Posted on: 31/03/2014 - 13:00

Treatment with metformin failed to show any positive effects on left ventricular function in diabetes-free patients who presented with ST-segment elevation MI, according to the results of a...

Field of Interest: Cardiology

Type: News Item

Neither perioperative aspirin nor clonidine prevents MI

Posted on: 31/03/2014 - 13:00

Neither perioperative aspirin therapy nor perioperative clonidine prevented death or MI in patients undergoing noncardiac surgery who were at risk for major vascular complications, according to data...

Field of Interest: Cardiology

Type: News Item

Patients with LBBB get bigger long-term survival bang from CRT-D

Posted on: 30/03/2014 - 23:40

WASHINGTON – Early treatment with cardiac-resynchronization therapy with a defibrillator showed a significant survival benefit in patients with mild heart failure, left ventricular dysfunction, and...

Field of Interest: Cardiology

Type: News Item

VIDEO: Study of hs-cTnT in chest pain intriguing, but flawed

Posted on: 30/03/2014 - 22:55

WASHINGTON – The lack of detectable high-sensitivity cardiac troponin T in patients presenting with chest pain may be a marker of minimal risk of myocardial infarction within 30 days, according to...

Field of Interest: Cardiology

Type: News Item

Ineffective renal denervation blamed for trial’s failure

Posted on: 30/03/2014 - 20:25

WASHINGTON – Renal denervation’s not so simple after all. Highly anticipated data from the large, sham-controlled renal-artery catheter denervation trial, SYMPLICITY HTN-3, gave its investigators...

Field of Interest: Cardiology

Type: News Item

‘Revolutionary’ LDL lowering shown in evolocumab phase III trials

Posted on: 30/03/2014 - 19:35

WASHINGTON – The novel low-density lipoprotein cholesterol–lowering agent evolocumab took day 1 of the annual meeting of the American College of Cardiology by storm on the strength of three...

Field of Interest: Cardiology

Type: News Item

ARB, ACE inhibitor at discharge curb heart failure readmissions

Posted on: 30/03/2014 - 18:15

WASHINGTON – Patients with acute heart failure who were discharged on an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker were significantly less likely to be readmitted to...

Field of Interest: Cardiology

Type: News Item

Old, reliable drugs cut heart failure readmissions

Posted on: 30/03/2014 - 17:30

WASHINGTON, D.C. – Heart failure patients discharged on inexpensive, guideline-recommended drugs were half as likely to be readmitted for the condition after 30 days, compared with those who weren’t...

Field of Interest: Cardiology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters